by Sarah Martin | October 6, 2014 | Health Risk Solutions, Health Risk Solutions General, Pharmacy, Preventive Care, Workplace Wellness
You may be wondering what impact the Ebola virus might have on your business and/or employees. Should your employees stop traveling? Just how contagious is the virus anyway? Lockton consulted with our medical, pharmacy, and benefits experts, plus some external...
by Sarah Martin | September 15, 2014 | Health Risk Solutions, Pharmacy
There has been much criticism around Gilead’s hepatitis C treatment, Sovaldi, which runs $84,000 per treatment. When we add in the cost of the other medications that must be taken in combination with Sovaldi, the total cost of treatment is around $95,000. Don’t expect...
by Sarah Martin | July 18, 2014 | Health Risk Solutions, Pharmacy
The high cost of Sovaldi, a breakthrough treatment for hepatitis C, has been garnering significant media attention. (See my previous post.) Now Express Scripts has taken that cost and extrapolated it to forecast what state governments might end up spending on new...
by Sarah Martin | July 17, 2014 | Health Risk Solutions, Pharmacy
As I described in a recent blog post (Peeking Behind the Curtain of Generic Medications), generic medications are not automatically less expensive than their brand equivalents. When a new generic drug is launched, there’s a period of exclusivity during which prices...
by Sarah Martin | July 8, 2014 | Health Risk Solutions, Pharmacy
Typically, when brand name drug patents are expiring and generic equivalents are about to hit the market, those affected most rejoice! And why wouldn’t they? Logic suggests that prices will immediately drop, helping employees who are on these medications and their...
